Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
|
|
KIORA PHARMACEUTICALS INC (KPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 4.8% stake in KIORA PHARMACEUTICALS, INC. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 9% stake in Kiora Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 14.4% stake in Kiora Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| Lind Global Fund II LP reports a 3.3% stake in Kiora Pharmaceuticals, Inc. |
| 01/27/2022 |
SC 13G/A
| BIGGER CAPITAL FUND L P has filed a Schedule 13D for Kiora Pharmaceuticals, Inc. f/k/a Eyegate Pharmaceuticals, Inc. |
| 01/24/2022 |
SC 13G/A
| Empery Asset Management, LP reports a 4% stake in Kiora Pharmaceuticals, Inc. |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2020 |
SC 13G/A
| Lau Jonathan reports a 0.4% stake in Eyegate Pharmaceuticals, Inc. |
| 04/18/2018 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 5% stake in Eyegate Pharmaceuticals, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/16/2018 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in EyeGate Pharmaceuticals, Inc. |
| 06/16/2017 |
SC 13G/A
| NATIXIS PRIVATE EQUITY reports a 3.6% stake in EyeGate Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| NATIXIS PRIVATE EQUITY reports a 6.4% stake in Eyegate Pharmaceuticals, Inc. |
|
|